Clinical Trials
Oxford Covid-19 vaccine: Serum Institute begins clinical trial in...
Serum Institute of India’s trial for ‘Covishield’ vaccine developed by the University of Oxford started with the first patients screened by Bharati Vidyapeeth Deemed University...
Clinical Trials
Australian COVID-19 vaccine shows promising results in animal trials
A COVID-19 vaccine candidate being developed by Australia’s University of Queensland has shown “positive” results against the novel coronavirus in preclinical tests, raising hopes for...
Clinical Trials
Trialbee Partners with Clinerion for Expanded Access to Global...
Trialbee, a leading global technology provider for patient matching and engagement in clinical trials, announced a partnership with Clinerion, a worldwide leader in medical data...
Clinical Trials
AstraZeneca Phase I clinical trial initiated for COVID-19 monoclonal...
The first participants have been dosed in a Phase I trial of AZD7442, a combination of two monoclonal antibodies (mAbs) in development for the prevention...
Clinical Trials
BMS Provides Update on Phase 3 IDHENTIFY Trial in...
Bristol Myers Squibb announced that the Phase 3 IDHENTIFY study evaluating IDHIFA® (enasidenib) plus best supportive care (BSC) versus conventional care regimens, which include best...
Clinical Trials
Byondis Initiates Phase I Study of Antibody-Drug Conjugate SYD1875
Byondis B.V. (formerly Synthon Biopharmaceuticals B.V.) announced that the first cancer patients have started treatment with its investigational antibody-drug conjugate (ADC) SYD1875.
The First-in-Human Dose-Escalation and...
Clinical Trials
Qu Biologics Initiates Phase 2 Study to Assess Activation...
Qu Biologics Inc., a biopharmaceutical company developing Site Specific Immunomodulators (SSIs), a novel platform of immunotherapies designed to restore innate immune function, is pleased to...
Subscribe
- Never miss a story with notifications
- Gain full access to our premium content
- Browse free from any location or device.